The US nutrition company uses robotics and chemistry to craft personalised nutritional products
Adam Monroe
Adam Monroe

Panaceutics Nutrition, a personalised nutrition company based in the US, has named veteran biotechnology executive Adam Monroe as its chief executive officer. “We are extremely excited to have Adam join our team,” said Andy Schwab, Panaceutics interim chief executive.

Founded in 2018, Panaceutics Nutrition applies proprietary robotics and chemistry to craft personalised nutritional products from numerous combinations that can be translated directly from genetic and medical diagnostics, condition recommendations or personal preferences.

Panaceutics raised $5 million in its Series A led by DSM Venturing, and with the participation of four investors.

Schwab explained the company’s goal for this past year has been to expand the executive management team with biotech leaders with the connections and insight to take Panaceutics to the next level. “Adam’s proven leadership will enable the next leap forward for our team to realize the full potential of our unique intellectual property portfolio,” he said.

Monroe brings more than 25 years of experience with industrial biotechnology, including the food and drink, and nutrition industries. He previously served as president, Americas, for Novozymes, a global biobased solutions company.

At Novozymes, Monrow led the Americas leadership team who collectively managed the sales, supply and development of a $900 million enzyme and microbial business in more than 30 markets across North and South America.

Monroe also led Novozymes global sustainability and public affairs efforts utilising an award-winning model with policy impact to the global business from Brussels to Brasilia, Beijing and Washington, DC. He has been a leading national voice for nature’s solutions and their sustainable impact on business and society.

Monroe argued that consumer focus on health and wellness is growing every day, along with the understanding of how we can better meet those needs through nutrition.

He said: “Human genetics, gut health and the microbiome, health monitors, nutraceuticals and functional medicine offer a myriad of possibilities if we can marry them with nutritional solutions at the right levels for the individual

“I’m amazed by Panaceutics’ technology and looking forward to working with them in Virginia and North Carolina to deliver solutions that uniquely match each individual consumer and improve the health and well-being of millions.”

Date published: 24 November 2020

Continue reading

Subscribe to get unlimited digital access.

Subscribe

Already a subscriber? Login